Metabolic dysfunction-associated fatty liver disease (MAFLD) is a new concept proposed in 2020. Unlike non-alcoholic fatter liver disease (NAFLD), the diagnosis of MAFLD requires the presence any of the following 3 metabolic risks, including overweight/obesity, presence of diabetes mellitus, and evidence of metabolic dysregulation. Continue reading “Diagnosis of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)”
Health care-associated pneumonia has been categorized as a discrete entity, with the goal of identifying patients with pneumonia that develops outside the hospital yet is caused by pathogens usually associated with hospital-acquired pneumonia or even ventilator-associated pneumonia, including methicillin-resistant Staphylococcus aureus (MRSA) and multidrug-resistant (MDR) gram-negative pathogens.
Continue reading “Criteria for Health Care–Associated Pneumonia”
o Steroidogenic enzyme deficiencies
§ Congenital adrenal hyperplasia
§ Aromatase deficiency
o Androgen-secreting tumors
o Exogenous androgens
§ Anabolic steroids
§ Transsexual hormone replacement
§ Idiopathic hirsutism
Continue reading “Syndromes or Disease Entities That Have Been Associated with Polycystic Ovaries”
Restless legs syndrome (RLS), also called Willis-Ekbom Disease, causes unpleasant or uncomfortable sensations in the legs and an irresistible urge to move them.
Continue reading “Diagnostic Criteria and Associated Features of Restless Legs Syndrome (RLS)”
DIC represents a continuum in clinical-pathological severity, characterised by the increasing loss of localisation or compensated control in intravascular activation of coagulation. Continue reading “Clinical Conditions Associated with Disseminated Intravascular Coagulation (DIC)”